2'-O-MOE-5-Methyl-Uridine Phosphoramidite is a chemically modified phosphoramidite building block used as a pharmaceutical intermediate in oligonucleotide synthesis. It incorporates a 2'-O-(2-methoxyethyl) (MOE) modification and a 5-methyluridine base, which enhance the stability and binding properties of synthetic oligonucleotides for research applications.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 163878-63-5
Thymidine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
nucleoside phosphoramidite for oligonucleotide synthesis
N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-((2-cyanoethoxy)(diisopropylamino)phosphino)-2'-O-(2-methoxyethyl)-5-methylcytidine
Phosphoramidite for oligonucleotide synthesis
(2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Nucleotide phosphoramidite building block
Adenosine, N-benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-, 3'-(2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite)
phosphoramidite for oligonucleotide synthesis
Mc-Val-Cit-PAB-Cl
Antibody-drug conjugate linker intermediate
2-((2,2-Diphenylvinyl)oxy)-4,6-dimethylpyrimidine
pharmaceutical intermediate
MC-Val-Ala-PAB-PNP
antibody-drug conjugate linker reagent
2,3,3-Trimethylindolenine
Pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
YFRRKZDUDXHJNC-KZQAAKLLSA-N
CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N)OCCOC